|Reviewer||Representation||Employment||Consultant||Speakers Bureau||Ownership/Partnership/Principal||Personal Research||Institutional, Organizational, or Other Financial Benefit||Expert Witness|
|Karen P. Alexander||Official Reviewer—AHA||Duke University, Duke Clinical Research Institute—Associate Professor||None||None||None||None||None||None|
|Deborah A. Chyun||Official Reviewer—AHA||New York University College of Nursing—Professor and Executive Associate Dean||None||None||None||None||None||None|
|Robert A. Harrington||Official Reviewer—ACC Board of Trustees||Stanford University—Professor and Chair, Department of Medicine||None||None||None||None||None||None|
|Geetha Raghuveer||Official Reviewer—ACC Board of Governors||Children’s Mercy Hospital—Cardiologist; University of Missouri Kansas City—Associate Professor of Pediatrics||None||None||None||None||None||None|
|Shannon Dunlay||Content Reviewer—AHA||Mayo Clinic—Cardiologist and Assistant Professor of Medicine||None||None||None||None||None||None|
|Samuel S. Gidding||Content Reviewer— ACC/AHA Task Force on Practice Guidelines||Nemours/Alfred I. duPont Hospital for Children—Chief, Division of Pediatric Cardiology||None||None||None||None||None||None|
|Michael Mansour||Content Reviewer—ACC Board of Governors||University of Mississippi Medical School; Delta Regional Medical Center, Cardiac Catheterization Laboratory—Director; Cardiovascular Physicians||None||None||None||None||None||None|
|Michael W. Rich||Content Reviewer—AHA||Washington University of Medicine—Professor of Medicine||None||None||None||None||None||None|
|Win-Kuang Shen||Content Reviewer— ACC/AHA Task Force on Practice Guidelines||Mayo Clinic Arizona, Phoenix Campus—Professor of Medicine||None||None||None||None||None||None|
This table represents the relationships of reviewers with industry and other entities that were disclosed at the time of peer review and determined to be relevant. It does not necessarily reflect relationships with industry at the time of publication. A person is deemed to have a significant interest in a business if the interest represents ownership of ≥5% of the voting stock or share of the business entity, or ownership of ≥$10,000 of the fair market value of the business entity; or if funds received by the person from the business entity exceed 5% of the person’s gross income for the previous year. A relationship is considered to be modest if it is less than significant under the preceding definition. Relationships that exist with no financial benefit are also included for the purpose of transparency. Relationships in this table are modest unless otherwise noted. Names are listed in alphabetical order within each category of review.
According to the ACC/AHA, a person has a relevant relationship IF: a) the relationship or interest relates to the same or similar subject matter, intellectual property or asset, topic, or issue addressed in the document; or b) the company/entity (with whom the relationship exists) makes a drug, drug class, or device addressed in the document, or makes a competing drug or device addressed in the document; or c) the person or a member of the person’s household, has a reasonable potential for financial, professional, or other personal gain or loss as a result of the issues/content addressed in the document.
ACC indicates American College of Cardiology; AHA, American Heart Association; and HHS, U.S. Department of Health and Human Services.